IN BRIEF: Futura Medical to raise GBP12 million to fund clinical study

Futura Medical PLC - Surrey-based pharmaceutical company - Plans to raise GBP10 million in ...

Alliance News 14 May, 2021 | 4:20PM
Email Form Facebook Twitter LinkedIn RSS

Futura Medical PLC - Surrey-based pharmaceutical company - Plans to raise GBP10 million in placing of shares at a price of 40 pence each, reflecting a discount of 21% to the company's closing price of 50.40 pence on Thursday.

Will also raised up to GBP2 million through a retail offer via the PrimaryBid platform at the same issue price.

Proceeds from the fundraising will go towards funding the small confirmatory clinical study required for the US FDA regulatory submission for MED3000 as a DeNoco medical device, as well as scale up its manufacturing activities, enabling lower costs for market launches.

Current stock price: 44.00 pence, down 13% on Friday

Year-to-date change: up sharply from 15.25p

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Futura Medical PLC 35.65 GBX 0.42 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures